Enochian Biosciences, Inc.
ENOB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $58,553 | $429,161 | $422,071 | $420,745 |
| - Cash | $625 | $93 | $923 | $312 |
| + Debt | $2,707 | $10,173 | $7,031 | $6,366 |
| Enterprise Value | $60,635 | $439,242 | $428,179 | $426,800 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $2,983 | -$115,202 | -$4,131 | -$4,514 |
| % Margin | – | – | – | – |
| Net Income | $2,819 | -$126,733 | $189 | -$7,252 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.13 | -0.76 | 0.001 | -0.04 |
| % Growth | 117.1% | -63,433.3% | 103% | – |
| Operating Cash Flow | -$1,349 | -$1,811 | -$1,487 | -$2,560 |
| Capital Expenditures | $0 | -$29,773,976 | $29,773,976 | $0 |
| Free Cash Flow | -$1,349 | -$29,775,788 | $11,804,307,400 | -$2,560 |